Abstract
No public abstract is available from the verified source records.
Bedis Elkamel, Shelby M. Meaders, Megan E. Murphy, Teresa A. Chueng, Hansel E. Tookes, Joy D. Scheidell
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Non-injection and injection drug use and STI/HIV risk in the United States: the degree to which sexual risk behaviors versus sex with an STI-infected partner account for infection transmission among drug users
10.1007/s10461-012-0276-0 · 2013
Trends over time in HIV prevalence among people who inject drugs in 89 large US metropolitan statistical areas, 1992–2013
10.1016/j.annepidem.2020.03.011 · 2020
Prevalence and modes of transmission of hepatitis C virus infection: a historical worldwide review
10.3390/v16071115 · 2024
Sexual risk behaviors and STDs among persons who inject drugs: a national study
10.1016/j.ypmed.2019.105779 · 2019
Narrative review: sexually transmitted diseases and homeless youth-what do we know about sexually transmitted disease prevalence and risk?
10.1097/olq.0000000000000633 · 2017
Increased methamphetamine, injection drug, and heroin use among women and heterosexual men with primary and secondary syphilis - United States, 2013–2017
10.15585/mmwr.mm6806a4 · 2019
Strategies used by people who inject drugs to avoid stigma in healthcare settings
10.1016/j.drugalcdep.2019.01.037 · 2019
Effectiveness of needle and syringe Programmes in people who inject drugs - an overview of systematic reviews
10.1186/s12889-017-4210-2 · 2017
unpaywall
Confidence 95%
datacite
Confidence 0%
Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020
10.1016/j.drugalcdep.2022.109323 · 2022
Reaching people who use drugs with sexual and reproductive healthcare through syringe services programs: potential promise and missed opportunities
10.1186/s12954-024-01116-5 · 2024
Expansion of syringe service programs in the United States, 2015–2018
10.2105/ajph.2019.305515 · 2020
Unresolved referenced work
Kept as external metadata until matched
A comparison of syringe disposal practices among injection drug users in a city with versus a city without needle and syringe programs
10.1016/j.drugalcdep.2011.12.001 · 2012
The University of Miami infectious disease elimination act syringe services program: a blueprint for student advocacy, education, and innovation
10.1097/acm.0000000000003557 · 2021
Student-run free clinic at a syringe services program, Miami, Florida, 2017–2019
10.2105/ajph.2020.305705 · 2020
Implementation and first-year operating costs of an academic medical center-based syringe services program
10.1186/s12954-021-00563-8 · 2021
Financial barriers, facilitators, and strategies among syringe services programs in the U.S., and their impact on implementation and health outcomes
10.1016/j.ssmqr.2024.100421 · 2024
Using interrupted time series analysis to measure the impact of legalized syringe exchange on HIV diagnoses in Baltimore and Philadelphia
10.1097/qai.0000000000002176 · 2019
Implementation of syringe services programs to prevent rapid human immunodeficiency virus transmission in rural counties in the United States: a modeling study
10.1093/cid/ciz321 · 2020
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Difference-in-difference in the time of cholera: a gentle introduction for epidemiologists
10.1007/s40471-020-00245-2 · 2020
Designing difference in difference studies: best practices for public health policy research
10.1146/annurev-publhealth-040617-013507 · 2018
Difference-in-difference estimation using Stata
2022
The wild bootstrap with a “small” number of “large” clusters
10.1162/rest_a_00887 · 2021
Revising the suspected-cancer guidelines: impacts on patients’ primary care contacts and costs
10.1016/j.jval.2022.06.017 · 2023
Unresolved referenced work
2024
Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis
10.1093/ije/dyt243 · 2014
Making the case for syringe services programs
10.1177/0033354920936233 · 2020
The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis
10.1097/qai.0b013e3181a2539a · 2009
The impact of syringe services program closure on the risk of rebound HIV outbreaks among people who inject drugs: a modeling study
10.1097/qad.0000000000003199 · 2022
Providing reproductive health services for women who inject drugs: a pilot program
10.1186/s12954-020-00395-y · 2020
Reducing missed opportunities: pairing sexually transmitted infection screening with syringe exchange services
10.1097/olq.0000000000000516 · 2016
Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis
10.1111/add.14012 · 2018
Needle exchange programs for the prevention of hepatitis C virus infection in people who inject drugs: a systematic review with meta-analysis
10.1186/s12954-017-0156-z · 2017
Per-contact infectivity of hepatitis C virus acquisition in association with receptive needle sharing exposures in a prospective cohort of young adult people who inject drugs in San Francisco, California
10.1093/ofid/ofaa092 · 2020
Prevalence of HIV and HCV among injecting drug users in three selected WHO-EMRO countries: a meta-analysis
10.1186/s12954-021-00505-4 · 2021
Reduction in injection risk behaviors after implementation of a syringe services program, Miami, Florida
10.1016/j.jsat.2021.108344 · 2021
Rapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions
10.1371/journal.pone.0104515 · 2014
Updates on syringe coverage and service uptake among needle and syringe programs in the United States, 2019–2020
10.1016/j.drugpo.2023.104289 · 2024
‘New evidence’ for Syringe Services Programs? A call for rigor and skepticism
10.1016/j.drugpo.2023.104107 · doi-reference
Approaches to offering hepatitis C treatment at syringe services programs in the United States: a scoping review
10.1093/ofid/ofaf211 · doi-reference
The impact of point-of-care hepatitis C testing in needle and syringe exchange programs on linkage to care and treatment uptake among people who inject drugs: an Australian pilot study
10.1111/jvh.13664 · doi-reference
Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL
10.1186/s12954-020-00385-0 · doi-reference